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Abstract
There is growing consensus that genome organization and long-range gene regulation involves partitioning of the genome
into domains of distinct epigenetic chromatin states. Chromatin insulator or barrier elements are key components of these
processes as they can establish boundaries between chromatin states. The ability of elements such as the paradigm b-globin
HS4 insulator to block the range of enhancers or the spread of repressive histone modifications is well established. Here we
have addressed the hypothesis that a barrier element in vertebrates should be capable of defending a gene from silencing
by DNA methylation. Using an established stable reporter gene system, we find that HS4 acts specifically to protect a gene
promoter from de novo DNA methylation. Notably, protection from methylation can occur in the absence of histone
acetylation or transcription. There is a division of labor at HS4; the sequences that mediate protection from methylation are
separable from those that mediate CTCF-dependent enhancer blocking and USF-dependent histone modification
recruitment. The zinc finger protein VEZF1 was purified as the factor that specifically interacts with the methylation
protection elements. VEZF1 is a candidate CpG island protection factor as the G-rich sequences bound by VEZF1 are
frequently found at CpG island promoters. Indeed, we show that VEZF1 elements are sufficient to mediate demethylation
and protection of the APRT CpG island promoter from DNA methylation. We propose that many barrier elements in
vertebrates will prevent DNA methylation in addition to blocking the propagation of repressive histone modifications, as
either process is sufficient to direct the establishment of an epigenetically stable silent chromatin state.
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Introduction
It has been proposed that genes and gene clusters are organized
into chromatin domains that are maintained independent of their
surroundings through the establishment of boundaries [1,2]. These
boundaries may be variable in position, resulting from a balance
between countervailing chromatin opening and condensing
processes. Alternatively, chromatin boundaries of fixed position
could be established by specific DNA sequence elements and their
associated binding proteins. Such elements, collectively called
insulators, possess a common ability to protect genes from
inappropriate signals emanating from their surrounding environ-
ment [3–7].
The chicken b-globin genes are clustered within a thirty kilobase
domain of nuclease accessible chromatin, the 59 boundary of
which is marked by a constitutive DNaseI hypersensitive site called
HS4 (Figure 1). The HS4 element has two activities that
functionally define insulators. First, it can block the action of an
enhancer element on a linked promoter, but only when positioned
between the two [8]. The protein CTCF mediates the enhancer
blocking activity of the HS4 element [9]. Second, the HS4
insulator acts as a barrier to chromosomal position effect silencing
[10]. The activities of HS4 have been mapped to a 275 bp ‘‘core’’
element that contains five protein binding sites revealed by DNase
I footprinting [9–11] (Figure S1). The enhancer blocking and
barrier activities of HS4 appear to have different underlying
mechanisms as they are separable in assay systems. The CTCF
binding site footprint II (FII) is necessary and sufficient for
enhancer blocking, but can be deleted from HS4 without affecting
barrier activity [9,12,13]. The four remaining protein binding sites
are all essential for barrier activity (FI, FIII, FIV and FV) but
dispensable for enhancer blocking activity [9].
We previously found that the binding of ubiquitous USF
proteins to a single site in HS4, footprint FIV, is a necessary
component of its barrier activity [14]. USF serves to constitutively
recruit several histone modifying enzymes, leading to the
enrichment of a panel of histone modifications typically associated
with transcriptionally active open chromatin, including H3ac,
H4ac, H3K4me2 and H4R3me2as. Knock down of USF
expression abolishes the recruitment of active histone modifica-
tions and leads to the encroachment of transcriptionally repressive
chromatin marked by H3K9me2 and H3K27me3 into the b-globin
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locus [14,15]. While USF function is necessary, it is not sufficient
for HS4’s barrier activity. Deletion of any one of the three
remaining HS4 binding sites FI, FIII or FV disrupts barrier
activity without affecting USF-mediated recruitment of histone
modifications to HS4 [12,14].
We hypothesized that the FI, FIII and FV sites may
contribute to barrier activity by preventing a transcriptional
silencing process other than that mediated by repressive
histone modifications. We previously observed that transgenes
lack promoter DNA methylation when shielded from chromo-
somal silencing by HS4 elements [16]. Similar results were seen
with retroviral transgenes shielded by HS4 [17]. It was not
clear from these studies whether the lack of DNA methylation
was an indirect consequence of transcriptional activity of
insulated transgenes, nor did these studies address whether
particular DNA elements or proteins bound at HS4 are
specifically responsible for this protection. We now use
insulator mutations to demonstrate that HS4 does specifically
protect a gene promoter from DNA methylation. We
determine which HS4 sequence elements are responsible for
protection from methylation and have purified the protein that
recognizes these elements in vivo. We also demonstrate that
these elements are able to mediate the demethylation of a CpG
island promoter.
Results
Three elements within the HS4 insulator protect a
promoter from DNA methylation
To investigate whether HS4 acts specifically to counter DNA
methylation, we have studied transgenic cell lines that were
previously established for the HS4 barrier assay. The assay
construct consists of an IL-2R reporter gene driven by an erythroid
enhancer and promoter randomly integrated into erythroid 6C2
cells. These transgenes are susceptible to chromosomal silencing
over a period of 20–40 days in culture following the removal of
selection, with transgenic promoters being subject to DNA
methylation and subsequent recruitment of the Mi-2/NuRD co-
repressor complex [12,16]. In contrast, transgenes flanked by wild-
type HS4 insulators are protected from silencing and lack
promoter DNA methylation [16,17]. It was unclear from these
earlier results whether the lack of methylation was a consequence
of transcriptional activity or whether particular HS4 activities
mediate protection from methylation.
We have performed clonal bisulfite sequencing on single/low-
copy transgenes flanked by HS4 insulators that are either wild type
or carry deletions in one of five protein binding site ‘footprints’
(Figure 1). We have studied the same stocks of the same cloned
transgenic cells that have been characterized for long term
expression and histone modification status [12,14]. The transgene
promoter remains free of DNA methylation when insulated from
chromosomal silencing by wild type HS4 elements, even following
prolonged culture (Figure 2B, WT). Strikingly, we find that
transgenic promoters are subject to almost complete DNA
methylation if any one of three footprinted sites, FI, FIII or FV,
is deleted from the flanking HS4 insulators (Figure 2, D1, D3 and
D5). These profiles of DNA hypermethylation are indistinguish-
able from those observed at non-insulated transgenes [16]. In
contrast, deletion of the CTCF (FII) binding site from HS4 results
in little de novo DNA methylation of the promoter (Figure 2B, DII).
The deletion of the CTCF site has no effect on barrier activity and
the lack of methylation observed is consistent with the transcrip-
tionally active state of this transgene (Figure 2C, [12]). De novo
DNA methylation of the transgene promoter has previously been
observed to be a secondary consequence of chromosomal silencing
in the absence of insulation [18]. This suggested that deletion of
the USF binding site from HS4, which abolishes HS4’s barrier
activity and results in the loss of active histone modifications [14]
and transcriptional silencing [12], should also result in promoter
hypermethylation. To our surprise, deletion of the USF (FIV)
binding site from HS4 results in little de novo DNA methylation of
the promoter (Figure 2B, DIV). These results show that the DNA
methylation status of a promoter does not necessarily follow its
histone modification and transcription status. They also strongly
Figure 1. Schematic representation of the chicken b-globin cluster and surrounding loci. Boxes represent the folate receptor (FR), b-globin
(r, bH, bA and e) and chicken olfactory receptor (COR) genes (not to scale). Arrows indicate DNaseI hypersensitive sites. The core of the HS4 element is
expanded to show the positions of the five in vitro footprinted sequences [11].
doi:10.1371/journal.pgen.1000804.g001
Author Summary
DNA sequences known as chromatin insulator or barrier
elements are considered key components of genome
organization as they can establish boundaries between
transcriptionally permissive and repressive chromatin
domains. Here we address the hypothesis that barrier
elements in vertebrates can protect genes from transcrip-
tional silencing that is marked by DNA methylation. We
have found that the HS4 insulator element from the b-
globin gene locus can protect a gene promoter from DNA
methylation. Protection from DNA methylation is separa-
ble from other insulator activities and is mapped to three
transcription factor binding sites occupied by the zinc
finger protein VEZF1, a novel chromatin barrier protein.
VEZF1 is a candidate factor for the protection of promoters
from DNA methylation. We found that VEZF1-specific
binding sites are sufficient to mediate demethylation and
protection of the APRT gene promoter from DNA
methylation. We propose that barrier elements in verte-
brates must be capable of preventing DNA methylation in
addition to blocking the propagation of silencing histone
modifications, as either process is sufficient to direct the
establishment of an inactive chromatin state.
VEZF1 Mediates Protection from DNA Methylation
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Figure 2. Three footprinted sites in the HS4 barrier protect a promoter from DNA methylation. (A) Schematic representation of the IL-2R
transgene drawn to scale with the distribution of CpG dinucleotides shown below. Promoter region CpG dinucleotides subject to bisulfite genomic
sequencing (BSEQ) analysis are indicated by the gray bar. (B) CpG methylation of transgene promoters flanked by wild-type or mutant HS4 insulators
after 30 (left) or 90 (right) days of culture. The percentage of methylation for each CpG from 10 clones is plotted. The average methylation for all CpGs
is indicated to the right of each plot. Scoring from individual clones can be found in Table S1. Numbers below each histogram refer to CpG
numbering from [16], where CpG 4–11 and 12–18 reside in the promoter and coding sequence, respectively. Data are representative of two
independent transgenic lines, with an average methylation variation of 7% or less. (C) Transgenic IL-2R expression for each line in (B) as monitored by
flow cytometry. WT and DII lines retain IL-2R expression, whereas DI, DIII, DIV and DV all succumb to silencing following 20–40 days of culture.
doi:10.1371/journal.pgen.1000804.g002
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indicate that three protein binding sites at HS4 (FI, FIII and FV)
have a specific role to mediate protection from silencing associated
with de novo DNA methylation.
Mutant insulators are partially methylated
We next sought to determine how HS4 footprint deletions affect
the timing and level of methylation of the mutant insulators in
comparison with their linked transgene promoters. The dogma
established from previous studies posits that a barrier element like
HS4 acts as a passive barrier to the propagation, or spreading, of
chromosomal silencing. We therefore expect that when HS4
mutations compromise barrier activity, the mutant insualtors
would become methylated either prior to, or coincident with, the
transgene promoters they are shielding. We performed bisulfite
sequencing of the HS4 elements that are located 59 of the IL-2R
transgenes (Figure 3A). Analyses were made following 30 days of
culture, typically the period at which epigenetic silencing of the
transgene is being established in non-insulated lines, and after 90
days, at which point any silencing will be complete. We find that
wild type HS4 elements remain unmethylated during long term
culture, concordant with the lack of transgene methylation
(Figure 3C, WT). Deletion of the FI and FV sites results in partial
methylation of HS4 (Figure 3C, DI and DV). This is in line with
the effects of these mutations on promoter methylation. The
timing of methylation does not fit the spreading models however,
as the transgene promoter becomes methylated prior to the
flanking insulator (compare DI at day 30 in Figure 2B with that in
Figure 3C). Furthermore, deletion of the FIII site does not result in
methylation of HS4 despite complete promoter methylation
resulting from this mutation (compare DIII at day 90 in
Figure 3C with that in Figure 2B). We also found that deletion
of either the CTCF or USF sites leads to partial methylation of
HS4, but with no methylation at the promoter (compare DII and
DIV at day 90 in Figure 3C with that in Figure 2B).
We note that the patterns of partial methylation of mutant HS4
elements are heterogeneous, with none of the individually
sequenced clones becoming densely methylated (Table S2). The
partial methylation of mutant HS4 elements (20%–50%) contrasts
with the near total DNA methylation observed at the silenced
promoters flanked by FI, FIII or FV site mutant insulators (90%–
100%). These findings reveal a disconnect between the level and
timing of de novo DNA methylation at a transgene and flanking
insulators.
Identification of HS4-binding activities
The footprinted sequences FI, FIII and FV are specifically
required for HS4’s ability to protect against DNA-methylation-
mediated silencing of a transgene. We wished to identify the
factors that interact with each of the FI, FIII and FV sites to better
understand this activity. We established gel mobility shift assays for
insulator-binding activities using nuclear protein extracts of the
chicken early erythroid cell line 6C2 (the cell line in which the
barrier assay is performed) and adult chicken red blood cells (an
abundant source of nuclear protein for purification purposes).
Complexes of similar mobility and intensity are observed between
the two nuclear extracts and each of the FI, FIII and FV sites
(Figure 4, 6C2 data not shown). Competition assays show that
these complexes are all specific for homopolymeric dG-dC strings
found in each site. Unlabelled wild type FI duplexes compete
efficiently with the formation of the major complex with FI,
whereas FI duplexes harboring mutations in the (dG-dC)9 string
are much less effective as competitors (Figure 4A, arrow, compare
lanes 2, 4 and 5). The major complex with FIII specifically
interacts with the (dG-dC)6 string at its center (Figure 4B, compare
lanes 1, 5, 6 and 7) and the major FV complex also specifically
interacts with bases in both of its (dG-dC) strings (Figure 4C,
compare lanes 1, 4, 5 and 7).
The same proteins interact with the FI, FIII and FV sites. This
is supported by the observation that the three sites can efficiently
compete with each other. Unlabelled FIII duplexes compete for
nuclear protein interactions with labeled FI (Figure 4A, compare
lanes 1 and 8) and FI duplexes efficiently compete for interaction
with FIII (Figure 4B, compare lanes 1 and 9), for example.
Mutational analysis shows that this cross-competition is dependent
upon the dG-dC string bases within each footprint site (data not
shown). Competition assays also reveal that the relative affinity of
nuclear proteins for the three sites differs somewhat. FI complexes
form with approximately 2- and 5-fold greater affinity than FIII
and FV complexes, respectively (data not shown). Together, these
observations of similar sequence specificity and comparable
complex mobilities indicate that common nuclear proteins interact
with all of these sites.
VEZF1 specifically interacts with G-rich sites in the HS4
insulator and the bA-globin promoter
We purified proteins that specifically interact with FI and FIII
from chicken red blood cells by conventional chromatography. FI-
and FIII-binding activities exactly co-fractionated following ion
exchange chromatography with SP- and Heparin sepharose
(Figure 5). The active elution peak from Heparin sepharose
chromatography was split in two and fractionated in parallel by
either FI or FIII DNA affinity chromatography. The resulting
purified polypeptides were sequenced by tandem mass spectrom-
etry (Figure S2). The proteins Hsp70, VEZF1, ZF5 and TEF1a
were present in both FI and FIII DNA affinity eluates. The
proteins SP1 and SP3 were additionally present in the FI DNA
affinity eluate.
We firstly cloned chicken VEZF1 (Refseq NM_001037827.1)
and determined whether it interacts with the G-rich footprinted
sites of the HS4 insulator, as it was previously reported that human
VEZF1 (also known as DB1) interacts with similar G-rich sites
[19,20]. We find that in vitro translation of chicken VEZF1 cDNA
yields a 65 kDa protein that efficiently interacts with the FI, FIII
and FV sites (Figure 6A). The complexes formed with recombinant
VEZF1 migrate slightly faster than those formed with nuclear
extract. This may be a reflection of differing post translational
modifications. Nonetheless, recombinant VEZF1 binds with an
identical specificity to that observed for nuclear extract proteins.
For example, competition of VEZF1 complexes with unlabelled FI
and FIII duplexes is disrupted by mutations within their dG-dC
strings (Figure 6A, lanes 1–8).
The (dG-dC) strings present in the VEZF1 sites at HS4 are
reminiscent of a site in the chicken bA-globin promoter that
contains a (dG-dC)16 string. A nuclear factor called Beta Globin
Protein 1 (BGP1) was previously characterized as interacting with
this site [21]. This BGP1 binding site has no effect on transcription
in transient assays or on chromatinized templates in vitro, but was
considered to indirectly assist in activation by directing nucleo-
some placement [22–24]. BGP1 protein of 66 kDa can be purified
using poly(dG)-poly(dC) affinity chromatography [25]. We have
now sequenced a purified BGP1 sample (a gift from J. Allan,
University of Edinburgh) and find it to be VEZF1. We find that
recombinant chicken VEZF1 interacts with the bA promoter site
with an identical specificity to that of erythrocyte nuclear protein(s)
(Figure 6A, compare lanes 9–15 with 16–22). At least seven
contiguous homopolymeric dG-dC base pairs are required for the
efficient formation of complexes between recombinant VEZF1 or
nuclear proteins and the bA promoter site [25]. Consistent with
VEZF1 Mediates Protection from DNA Methylation
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Figure 3. Mutations of insulator protein binding sites result in the de novomethylation of HS4 itself. (A) Schematic representation of the
IL-2R transgene including the upstream HS4 elements subject to bisulfite genomic sequencing analysis (gray horizontal bar below CpG plot). (B)
Schematic representation of a 275 bp HS4 core element, drawn to scale. Footprinted sequences are shaded gray. CpG locations with their assigned
numbers are shown above. Horizontal bars indicate bases subject to deletion. (C) CpG methylation of wild-type (WT) or mutant (DI - DV) HS4
insulators after 30 (left) or 90 (right) days of culture. Both copies of HS4 were sequenced, except for DII and DV, where only the outermost copy was
sequenced (see Materials and Methods). The percentage of methylation for each CpG from 10 clones is plotted. The average methylation for all CpGs
is indicated to the right of each plot. Scoring from individual clones can be found in Table S2. Numbers below each histogram refer to CpG
numbering as assigned in (B). Horizontal gray bars indicate deleted CpGs. Data are representative of at least two independent transgenic lines, with
an average methylation variation of 12% or less.
doi:10.1371/journal.pgen.1000804.g003
VEZF1 Mediates Protection from DNA Methylation
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this, interaction between VEZF1 and the bA site is competed by
unlabelled FI which contains a (dG-dC)9 string (Figure 6A,
compare lanes 16 and 20). This competition is disrupted by
mutation at the centre of the FI dG-dC string (Figure 6A, compare
lanes 20 and 21). However, VEZF1 interaction with the bA site is
also competed by FIII which contains only a (dG-dC)6 string
(Figure 6A, compare lanes 16 and 22). FIII contains a second short
(dG-dC)4 string, as does FV (see figure 4D), which may
compensate to form a bipartite recognition motif. Recombinant
VEZF1 interacts with the contiguous dG-dC strings of the FI and
bA sites with approximately 2- and 5-fold greater affinities than the
bipartite dG-dC strings of the FIII and FV sites, respectively (data
not shown).
Polyclonal antibodies were raised against a conserved C-
terminal fragment of VEZF1, which specifically recognize the
65 kDa VEZF1 polypeptide from chicken nuclear extracts (Figure
S7B). VEZF1 antibodies readily supershift/abrogate complexes
between recombinant VEZF1 and the FI, FIII, FV and bA sites
(Figure 6B). Supershift analysis also reveals that VEZF1 is present
in complexes between nuclear extracts and the FI, FIII, FV and bA
sites (Figure 6B). VEZF1 appears to be the only factor that
interacts with the FIII and FV sites, whereas other factors also
appear to bind to the FI and bA sites in vitro.
Chromatin immunoprecipitation (ChIP) analyses were per-
formed to analyze the binding of VEZF1 at the chicken b-globin
locus in vivo. Chromatin was prepared from the early erythroid line
6C2, which does not express b-globin and nucleated erythrocytes
isolated from 10 day chicken embryos, a stage at which
approximately 80% of erythrocytes are definitive and express the
bA-globin gene. VEZF1 was found to strongly interact with HS4 in
both 6C2 cells and erythrocytes, consistent with our in vitro
analyses (Figure 7A and 7B). VEZF1 binding to HS4 therefore
does not coincide with transcription of the b-globin genes. VEZF1
does not interact with the 39HS enhancer blocking element, which
does not contain any dG-dC string like motifs and lacks barrier
activity [12]. This is in contrast to CTCF, which interacts strongly
with both the HS4 and 39HS insulators in 6C2 cells and
erythrocytes (Figure 7A and 7B). We also find that VEZF1
strongly interacts with the bA promoter, consistent with gel
mobility shift assays. In contrast to HS4, VEZF1 binding to the bA
promoter appears to be restricted to erythrocytes in which the bA
gene is expressed (Figure 7A and 7B). None of the other candidate
HS4-binding proteins isolated by DNA affinity purification were
found to bind in vivo (described in Text S1) (see also Figures S3, S4,
S5).
We tested whether VEZF1 requires all three of its sites for
binding to HS4 in vivo, as all three VEZF1 binding sites are
required for protection from DNA methylation. We found that this
was not the case, as VEZF1 remains tightly bound at HS4 when
any one of its binding sites is deleted (Figure S6). VEZF1 also
remains bound to mutant HS4 elements that have become
partially methylated. Consistent with this, we found that VEZF1
Figure 4. Nuclear proteins specifically interact with the dG-dC strings at HS4 footprints I, III, and V. (A–C) Gel mobility shift analysis of
interactions between chicken adult erythrocyte nuclear extract and 32P-labelled FI (A), FIII (B), and FV (C) oligonucleotide duplexes. Unlabelled
competitor duplexes (indicated above each lane) were added at 50 fold molar excess. Arrows indicate footprint sequence-specific complexes.
Asterisks indicate a non-specific FI complex in (A) and an FV complex that was not pursued further due to inconsistent abundance in (C). (D)
Sequences present in competitor oligonucleotides. Mutations shown in bold lower case. Footprinted bases are indicated by shading. Bases that are
essential for maximal binding are underlined; mutations of other bases had no effect on binding (A–C, data not shown).
doi:10.1371/journal.pgen.1000804.g004
VEZF1 Mediates Protection from DNA Methylation
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binding to its three sites at HS4 is not affected by CpG
methylation in vitro (data not shown). We have attempted to
disrupt VEZF1 function at HS4 following knockdown by RNAi.
We strived to achieve substantial knockdown of VEZF1 to disrupt
its binding to the high affinity sites at HS4. Prolonged knockdown
was also required as we have previously found that the de novo
DNA methylation of these transgenes is a gradual process that
takes many days to establish [18]. We were able to knockdown
VEZF1 protein to 3% of wild type levels following 2 weeks of
stable miRNA expression. However, ChIP analysis revealed that
VEZF1 binding to HS4 was not significantly affected following this
prolonged and substantial knockdown (Figure S7). Consequently,
we observed no de novo DNA methylation of the HS4 element and
no change in HS4’s ability to protect a transgene from silencing
during this period (data not shown). The inadequacy of RNAi to
strip constitutive transcription factor binding from high affinity
sites has also been observed for CTCF [26]. Unfortunately, we are
unable to study the role of murine Vezf1’s role in protection from
DNA methylation in Vezf1 null ES cells, as we recently found that
they are defective for de novo DNA methylation due to the
requirement of Vezf1 for full transcriptional activity of the Dnmt3b
gene in these cells [27].
VEZF1 elements protect a CpG island from de novo DNA
methylation
To address whether VEZF1 elements also protect CpG island
(CGI) promoters from DNA methylation, we investigated VEZF1
binding to the APRT gene promoter and its effects on methylation.
SP1-like binding elements have been shown to be required to
prevent methylation of the mouse and hamster APRT CpG island
elements: two earlier papers have shown that deletion of the SP1-
like elements is sufficient to induce methylation in these islands
[28,29]. Furthermore, pre-methylated fragments of the hamster
APRT CGI that contain three SP1-like elements are subject to
demethylation upon integration into mouse ES cells [28]. The
SP1 transcription factor itself is not required for the unmethylated
state of CGIs however, with the APRT gene remaining
unmethylated and expressed normally in Sp1 null ES cells and
embryos [30]. Given that VEZF1 recognizes G-rich sequences
that are similar to SP1 motifs, we hypothesized that VEZF1 may
interact with the APRT CGI elements (Figure 8A). We performed
ChIP analyses for the binding of SP1 and VEZF1 to the 720 bp
hamster APRT CGI stably integrated into mouse ES cells
(Figure 8B). We found SP1 binding at both sites 1/2 and site 3,
but site 3 was also occupied by VEZF1. Supershift analysis also
shows VEZF1 interaction with site 3 in vitro (Figure S8). Site 3
contains a motif (CCCCCCTTTCCCC) that is reminiscent of the
VEZF1-specific bipartite footprint III site found at the HS4
insulator element (CCCCCCGCATCCCC).
To address whether VEZF1 elements could protect the APRT
CGI from methylation, we replaced each of the three SP1-like
elements with the VEZF1-specific FIII element from the HS4
insulator (Figure 8A). ChIP analysis shows that VEZF1 binding
replaces that of SP1 at the mutant APRT CGI integrated into ES
cells (Figure 8B). Supershift analysis also shows that VEZF1
interacts with the mutant sites 1&2 and site 3, while SP1/SP3
binding is lost (Figure S8). We then tested the ability of wild type
and mutant APRT CGIs to resist DNA methylation. Firstly, we
confirmed that the de novo DNA methylation machinery
functioned normally in the ES cells as non-island sequences from
the APRT gene body succumb to de novo methylation (Figure 8C).
Consistent with previous results [28,29], we find that the wild type
APRT CGI is protected from DNA methylation when stably
integrated into ES cells (Figure 8D). Furthermore, a pre-
methylated wild type APRT CGI is demethylated upon integra-
tion (Figure 8E). It has previously been shown that mutation of the
SP1-like elements results in the de novo methylation of the APRT
CGI [28]. Our results show that substitution of the SP1-like
elements with VEZF1-specific FIII elements from HS4 restores
the ability of the mutant APRT CGI to be both protected from de
novo methylation and to remove pre-methylation (Figure 8E and
8F). VEZF1 elements from HS4 are therefore sufficient to
mediate the demethylation and protection of a CGI from DNA
methylation.
Figure 5. Purification of FI- and FIII-binding proteins. Schematic
representation of the steps used to purify DNA-binding proteins from
adult erythrocyte nuclear protein (NP) extracts that interact with FI and
FIII sequences. Numbers in the workflow indicate the salt concentration
(mM) at which DNA binding factors eluted from each column. DNA
binding activity was tracked using gel mobility shift analysis and the
sequence specificity of complex-forming factors was checked by
competition analysis following each purification stage (data not shown).
FI- and FIII-binding activities exactly co-purified. The eluate pool from
the Heparin step was split in two prior to either FI or FIII DNA affinity
chromatography. SDS-PAGE of proteins eluted from DNA affinity
columns at 400 mM KCl visualized with colloidal Coomassie is shown
below. The size of each polypeptide (kDa) is indicated.
doi:10.1371/journal.pgen.1000804.g005
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Figure 6. VEZF1 specifically interacts with dG–dC strings within HS4 footprints I and III and the bA-globin promoter. (A) Gel mobility
shift analysis of interactions with 32P-labelled HS4 FI, and FIII, or bA-globin promoter ‘glo wt’ oligonucleotide duplexes. Unlabelled competitor
duplexes (indicated above each lane) were added at 50 fold molar excess. Adult chicken erythrocyte nuclear extract (ery) or recombinant chicken
VEZF1 were used as indicated by brackets above the lanes. Arrows indicate footprint sequence-specific complexes. (B) Gel mobility supershift assays
using 32P-labelled FI, FIII, FV, and glo wt oligonucleotide duplexes. Proteins were pre-incubated with anti-VEZF1 antibodies (indicated above each
lane) prior to incubation with DNA. VEZF1 supershifts are evidenced by either abrogation of specific complexes (asterisks) and/or formation of low
mobility ternary complexes (SS). Antibodies alone do not give rise to complexes with any of the duplexes used (data not shown). Supershift
experiments shown are cropped from the full gels shown in Figure S3. (C) Sequences present in oligonucleotides used in gel mobility shift assays.
dG–dC strings and their mutations are bold and underlined, respectively.
doi:10.1371/journal.pgen.1000804.g006
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Discussion
Here we have studied the paradigm HS4 element to address our
hypothesis that a barrier element in vertebrates must be capable of
defending a gene from silencing by DNA methylation and have
identified a novel CpG island factor. We have presented six
findings: 1) a vertebrate barrier element protects a gene promoter
from DNA methylation-mediated silencing, 2) the essential
transcription factor VEZF1 is a barrier/anti-methylation factor,
3) there is a modular division of labor at the compound HS4
insulator as VEZF1-mediated protection from methylation is
separable from CTCF-mediated enhancer blocking and USF-
mediated recruitment of active histone modifications, 4) the de novo
DNA methylation activity prevented by the HS4 barrier does not
appear to spread from its chromosomal neighborhood, 5) a
promoter can be protected from DNA methylation even when it
lacks active histone modifications and transcriptional activity, and
6) short DNA elements bound by VEZF1 mediate the demeth-
ylation and protection of a CpG island from DNA methylation.
The barrier activity of HS4 consists of separable activities
which prevent silencing mediated by either histone or
DNA methylation
We have previously demonstrated that the HS4 insulator acts as
a barrier to the spread of histone methylation marks associated
with repressive chromatin [14,15]. While we found that active
histone modifications recruited by USF proteins are an essential
component of HS4’s barrier activity, they are not sufficient [14].
Three addition protein binding sites are essential for barrier
activity but are not required for the recruitment of active histone
modifications [12,14]. These findings, summarized in Figure 9,
indicated that there was an additional and separable component to
HS4’s barrier activity. Here, we show that all three sites are bound
by VEZF1 and are required for HS4’s ability to protect a linked
promoter from de novo DNA methylation.
It was previously shown that the transgenes used in this study
become marked by dense promoter DNA methylation upon
chromosomal position effect silencing [16]. Promoter DNA
methylation occurred subsequent to histone deacetylation and
transcriptional inactivation of the promoter [18]. While flanking
HS4 elements perfectly shield the transgene from silencing and
DNA methylation, it was unclear from these experiments whether
the lack of promoter methylation was simply a readout of the
promoter’s transcription status. We show that VEZF1-mediated
protection from DNA methylation of a transgene promoter is
retained even when USF site mutations at HS4 lead to histone
deacetylation and transcriptional silencing (Figure 9, DUSF). The
separation of DNA methylation protection from a promoter’s
histone modification and transcriptional status is a strong
indication that the VEZF1 sites at HS4 possess a bona fide activity
that is protective against DNA methylation.
De novo DNA methylation of a transgene does not
appear to propagate via a continuous DNA methylation-
dependent spreading mechanism
Determining the source of de novo DNA methylation is key to our
understanding of how VEZF1 binding at HS4 could protect a
promoter from epigenetic silencing. Previous studies using the
same transgene system studied here found that non-insulated
transgenes, regardless of integration site, are consistently subject to
promoter methylation upon chromosomal silencing, and that
flanking with HS4 elements can shield transgenes from this
methylation [16,18]. The simplest explanation of these results is
that HS4 is acting as a barrier to the encroachment, or spreading,
of a silencing mechanisms that results in DNA methylation. The
ability of repressive histone modifications and associated chroma-
tin factors to mediate the spreading of gene silencing is well
documented for many systems [31]. In the case of the chicken b-
globin locus, the spreading of repressive histone modifications is
observed upon perturbation of active histone modification
recruitment at the HS4 barrier [14,15]. Analyses of progressive
CpG island methylation during tumor progression are consistent
with models that describe the spreading of DNA methylation
[32,33].
Should de novo DNA methylation arise via spreading from the
chromosomal integration site in our transgene system, we would
expect to see high levels of methylation at compromised mutant
insulators either coincident with, or prior to promoter methylation.
However, we observe that promoters become methylated prior to
the insulators, which remain unmethylated or become partially
methylated. The observed independence of methylation states
between insulator and promoter argue against spreading and
clearly show that there can be no single mechanism that controls
the methylation state of both the insulator and promoter. It
remains possible that VEZF1 elements at HS4 are acting as a
barrier to the spreading of a DNA methylation mechanism, but
that additional processes prevent the accumulation of methylation
at HS4 itself. An alternative possibility is that DNA methylation
does not result from spreading, and that the insulator directly
interacts with the promoter to deliver VEZF1 co-factors that
prevent promoter methylation. In this model, the promoter itself
would have its own program to recruit de novo DNA methylation,
and VEZF1 would act as a factor that mediates inhibition of
methylation. This would distinguish the activity of VEZF1 from
those of USF1/USF2, which bind elsewhere in the insulator
element and recruit a number of enzymes that deliver active
histone modifications to the reporter gene [14,15,34]. It will be of
interest in future to determine whether VEZF1 elements
potentiate the expression of nearby genes through the control of
DNA methylation.
Intact insulator protein complexes maintain HS4 as a CpG
island
The 275 bp ‘‘core’’ HS4 element comprises a CpG island (CGI)
that is free of DNA methylation regardless of neighboring gene
Figure 7. VEZF1 interacts with the HS4 insulator in vivo. (A) ChIP
analysis of VEZF1 and CTCF interactions at the b-globin locus in (A) 6C2
erythroid progenitor cells or (B) 10 day embryonic erythrocytes. DNA
enrichments at the bA promoter or the HS4 and 39HS insulators were
normalized to a negative control located in the 16 kb condensed
chromatin region upstream of the b-globin locus.
doi:10.1371/journal.pgen.1000804.g007
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expression [11,35,36], as well as when it is inserted into the mouse
Igf2/H19 domain [37]. Consistent with this, we found that wild
type transgenic HS4 elements remain unmethylated during long
term culture. The processes that maintain the unmethylated state
of the insulator appear to be complex, as we find that the mutation
of all insulator protein binding sites results in some degree of de
novo DNA methylation of HS4. It has previously been shown that
DNA binding proteins can prevent the methylation of their
binding sites simply by steric hindrance of de novo DNA
methyltransferases (DNMTs) [38]. It is possible that the HS4
deletions studied here disrupt cooperative interactions between
insulator proteins, thus permitting DNMT access. We performed
ChIP experiments on HS4 mutants and found that deletion of any
one insulator binding site does not lead to the loss of binding of
another (Figure S6). This is in agreement with functional assays
which also found that deletion of any one insulator protein binding
site does not lead to the loss of function associated with another site
[9,12,14]. These findings argue against a simple steric protection
of HS4 DNA from DNMTs by transcription factor binding. The
degree of methylation at mutant HS4 elements was typically
moderate (20–50%) and did not increase to the near total
methylation seen at the transgene promoter (90–100%) following
Figure 8. VEZF1 elements protect a CpG island from de novo DNA methylation. (A) Scale representation of the 700 bp hamster APRT CpG
island (CGI). The positions of AvaII (A) and HpaII (H) restriction sites are indicated. The locations of putative SP1 and VEZF1 binding motifs in the wild
type (wt) sequence are shown. The sequence alterations in the mutant (mut) are shown beneath, where all three SP1/VEZF1 motifs are replaced with
the VEZF1-specific footprint III (CCCCCCGCATCCCCGA) sequence from the HS4 insulator. (B) ChIP analysis of SP1 and VEZF1 interactions with stably
integrated hamster APRT CGI sequences in mouse ES cells. PCR primers flanking either sites 1 and 2 (1&2) or site 3 were used to detect interactions
with either the wild type (wt) APRT CGI or the mutant (FIII mut) containing VEZF1-specific sites. PCR products shown are ,180 bp in size. DNA
enrichments relative to input and normalized to no antibody control are shown (C) Methylation specific PCR (MSP) analysis of a stably integrated non-
island region of the APRT locus. Genomic DNA was digested with either of the isoschizomers MspI (M) or CpG methylation-sensitive HpaII (H),
followed by PCR over the CpG-containing sites. Increased PCR product from HpaII relative to MspI digested DNA demonstrates the presence of de
novo methylation at these sites in ES cells. Two representative lines are shown. (D–G) VEZF1 sites are sufficient for the demethylation of the APRT CpG
island. Southern blotting of APRT CpG island elements stably integrated into ES cells. Genomic DNA was digested with AvaII alone (A) or with AvaII
and HpaII (AH). Digestion of the ,600 bp AvaII parent fragments with HpaII indicates the absence of DNA methylation. (D,E) Representative lines
harboring the wild type APRT CGI that was unmethylated or in vitro methylated with M.SssI prior to integration. (F,G) Two representative lines
harboring the mutant APRT CGI, whose SP1 motifs are substituted with VEZF1-specific FIII sites from HS4, that were unmethylated or pre-methylated
prior to integration.
doi:10.1371/journal.pgen.1000804.g008
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long term culture. These observations are consistent with a
balance between activities that add and remove DNA methylation
at HS4.
VEZF1 elements at CpG island promoters
All constitutively expressed genes and ,40% of genes with
tissue-restricted expression have CGI promoters [39]. CGIs are
typically unmethylated, especially in the germ line, which ensures
that these CpGs are not subject to mutation by spontaneous
deamination. It remains to be determined how CGIs resist global
de novo methylation during early development, and how they
remain hypomethylated irrespective of transcriptional status.
Recent epigenomic profiling studies have begun to reveal a
significant portion of CGIs that are subject to varying degrees of
tissue-specific methylation in human somatic tissues [40–42].
These findings point to the existence of processes that protect
CGIs from de novo methylation, which can be selectively
inactivated during development and may become defective during
cancer progression [43]. Definition of the cis-regulatory elements
and trans-acting factors that control CGI methylation status is key
to unraveling these processes.
We have revisited the well established example of the APRT
gene CGI promoter. It was previously shown that SP1-like binding
elements are required to prevent CGI methylation [28,29],
although surprisingly the SP1 transcription factor itself is not
required [30]. These findings suggested that other factors function
at the G-rich SP1-like motifs, which are commonly found at CpG
islands [44]. We show that VEZF1 interacts with site 3 of the
hamster APRT CGI. A promoter-less APRT CGI fragment
containing only site 3 remains protected from DNA methylation
[28]. We were able to abrogate SP factor binding while retaining
VEZF1 binding by introducing VEZF1-specific elements. The
VEZF1-specific mutant retained its ability to mediate demethyl-
ation and protection from de novo DNA methylation. Thus, VEZF1
binding elements can protect a CGI from DNA methylation. We
attempted to definitively address the requirement for VEZF1, but
discovered that global de novo DNA methylation mechanisms are
defective in Vezf1 null ES cells [27]. We also show that VEZF1
interacts with the CGI promoter of the DHFR gene (Figure S5).
Furthermore, ChIP-array analysis in somatic human cells reveals
that VEZF1 predominantly interacts with CGI promoters and
regulates genes with diverse functions (R.S. and A.W., unpub-
lished observations). It remains to be determined whether VEZF1
plays a widespread role in the control of DNA methylation and
what contribution this epigenetic control makes to developmental
gene regulation and cancer progression.
DNA methylation and the multiple roles of chromatin
boundaries
Experimental evidence has demonstrated that chromatin barrier
elements can employ a number of different mechanisms to limit the
spread of transcriptionally repressive chromatin; including tether-
ing, nucleosome gaps/masking and histone code manipulation [6].
The constitutive recruitment of histone modifications such as
acetylation is considered to be sufficient to establish barrier activity
in eukaryotes that do not methylate their genomes, as demonstrated
at synthetic barriers in yeast [45]. Our finding that HS4 also
mediates protection from de novo DNA methylation adds another
tier to understanding the mechanism of barrier elements in
vertebrates. It is well established that densely methylated DNA
abrogates transcription factor binding and is sufficient to establish
all the features of repressive chromatin, including repressive histone
modifications [46,47]. We propose that a barrier element in higher
eukaryotes must be capable of preventing de novo DNA methylation
in addition to blocking the propagation of silencing histone
modifications, as either event, if not inhibited, is sufficient to direct
the establishment of an epigenetically stable silent chromatin state.
We have shown here that a fully effective vertebrate barrier
combines both of these properties in a single multi-component
element.
Materials and Methods
Bisulfite sequencing analysis
Chicken 6C2 erythroleukemia cells carrying IL-2R reporter
transgenes (8103, wild type HS4; 10401, DFI; 10506, DFII; 10615,
DFIII; 10901, DFIV; 8d5, DFV) were cultured and assayed for IL-
2R expression by FACS as described previously [12,14]. Genomic
DNA was extracted from cell lines after 30 and 90 days of culture
and bisulfite modified (EZ Methylation, Zymo Research, CA). The
upstream double-core HS4 elements and the IL-2R promoter
were PCR amplified from each line. We were unable to amplify
bisulfite modified double-core HS4 elements from the 10506, DFII
Figure 9. Shielding of a transgene by the multi-component HS4
barrier element. The observed effects of insulator protein binding site
mutations on the DNA methylation (this study), histone modification
[14] and transcriptional status (this study and [12]) of a transgene
insulated by HS4. A schematic representation is shown where HS4
harbors one CTCF (purple), one USF (green) and three VEZF1 (red)
binding sites. Transcriptional activity of the reporter gene is indicated
with an arrow. The histone modification status is depicted above each
transgene, where high and minimal levels of H3ac and H3K4me2 are
represented as ac/me and -/-, respectively. The DNA methylation status
of the promoter and upstream insulators is indicated below each
transgene where open and filled circles represent unmethylated and
methylated bases, respectively. Shades of methylation are an approx-
imation of the data presented in Figure 1 and Figure 2. Mutation of the
CTCF site disrupts enhancer blocking activity [9] but has no effect on
barrier activity of HS4. USF site mutation disrupts the recruitment of
active histone modifications, resulting in transcriptional silencing. The
promoter remains unmethylated in USF mutants due to the action of
VEZF1. VEZF1 site mutations abrogate barrier activity despite USF-
mediated recruitment of histone modifications remaining intact. VEZF1
mutants are characterized by complete promoter methylation.
doi:10.1371/journal.pgen.1000804.g009
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line to sufficient levels to provide representative sequence data. We
therefore opted to amplify the outermost HS4 copy only. The 8d5,
DFV line also only contains one copy of HS4 in the upstream
location [12]. All PCR products were gel purified and cloned,
followed by sequencing (GATC Biotech, Konstanz, Germany) of
10 clones for each region of interest.
Gel mobility shift assays were performed as described previously
[14]. Recombinant VEZF1, SP1, SP3 and ZF5 were produced by
in vitro translation using rabbit reticulocyte lysate (Promega).
Protein purification
FI- and FIII-binding proteins were purified from adult chicken
red blood nuclear protein extracts by ion exchange chromatog-
raphy. Throughout the purification, eluate fractions were analyzed
for FI- and FIII-binding activity with gel mobility shift assays. The
binding specificity of partially purified proteins was checked by
competition analysis after each purification step. FI- and FIII-
binding activities co-fractionated following ion exchange chroma-
tography with SP XL and Heparin sepharose (GE Healthcare).
Phosphocellulose, Q and Sephacryl S300 columns were used in
early purification attempts to resolve FI- and FIII-binding
activities but they co-fractionated in each case (data not shown).
FI- and FIII-binding activities both eluted in two distinct fractions
of approximately 200 and 400 kDa following gel filtration (data
not shown). The active fractions eluted from heparin sepharose
were pooled then split into two and fractionated in parallel by FI
or FIII DNA affinity as described previously [14]. Polypeptides
electrophoresed on 7% Tris-acetate gels (Invitrogen) were excised,
digested with trypsin and sequenced at the Harvard Microchem-
istry Facility by microcapillary reverse-phase HPLC nano-electro-
spray tandem mass spectrometry (mLC/MS/MS) on a Finnigan
LCQ DECA quadrupole ion trap mass spectrometer.
cDNA cloning
Chicken VEZF1/BGP1 cDNA was cloned following RT-PCR
from 6C2 cell total RNA based on an assumption of conservation
of 59 cDNA sequence with human VEZF1/DB1. The oligonu-
cleotide Adaptor-A 59CATGCCGCTCGAGCGGTTTTTTTT-
TTTTTTTTT was used in first strand cDNA synthesis with
Superscript II reverse transcriptase (Invitrogen). The primers
VEZF1_59, 59CCATGACCCATGGGCAGAGCCAAAGT and
Adaptor 59CATGCCGCTCGAGCGG were used to amplify a
full length chicken VEZF1 cDNA by PCR which was TA cloned
into pCRII (Invitrogen). VEZF1 cDNA was sub-cloned into
pCITE4b (Novagen) to generate p4bVEZFfull for the purpose of
in vitro transcription. cDNA encoding chicken ZF5 was isolated by
RT-PCR from 6C2 cell total RNA using primers designed from
the published sequence (U51640). We found that the bases CpG
1306-7 in the published sequence were GpC in our clone, causing
codon 436 to translate as alanine instead of arginine. We obtained
the vectors pCDNA3-ZF5 and pEVRFO-ZF5 (a kind gift of W.
Stumph, San Diego State University) and we also found the CpG
to GpC conflict with the published sequence. Full length chicken
SP1 and SP3 cDNAs cloned in the pBluescript-based vectors pH-
SP1 and pH-SP3-3 were a kind gift from Marc Castellazzi
(INSERM, Lyon).
Antibodies
Polyclonal antibodies were raised (Rockland Immunochemicals)
against chicken VEZF1 (Ser376-Ala547) and chicken ZF5 peptides
(Ser131-Lys248) produced in E.coli (QIAexpress, Qiagen). Peptides
were produced in M15 [pREP4] E. coli followed by rapid lysis with
B-PER reagent (Pierce). ZF5 peptide was soluble and purified on
Ni-NTA agarose (Qiagen). VEZF1 peptide was insoluble and
resulting inclusion bodies were prepared using B-PER reagent
(Pierce), solubilized with 6M guanidium hydrochloride and
immobilized on TALON Sepharose resin (Clontech) at pH 7.
VEZF1 peptide was renatured in a stepwise manner with 6, 4, 3, 2,
1 and 0.5 M guanidium hydrochloride prior to elution. VEZF1
and ZF5 polyclonal IgG antibodies (Rockland Immunochemicals)
were purified from rabbit serum using PROSEP-A media
(Montage, Millipore). Anti-full length chicken VEZF1 antibodies
were raised previously [27]. Antibodies raised against CTCF (06-
917), SP1 (PEP2X, H-225X), SP3 (D20X) and USF1(B01) were
obtained from Millipore, Santa Cruz Biotechnology and Abnova,
respectively.
Chromatin immunoprecipitation (ChIP) analysis
ChIP analysis of transcription factor binding in chicken cells was
performed using formaldehyde crosslinked chromatin prepared
from chicken 10 day embryonic erythrocytes isolated from
fertilized White Leghorn eggs (CBT Farms, Chestertown, MD)
or cultured 6C2 erythroleukemia cells. 10 day erythrocytes were
washed and resuspended in 25 mls of PBS (26107 cells/ml) and
fixed with a final concentration of 0.25% formaldehyde at room
temperature for 30 seconds. 6C2 cells were harvested in mid-
exponential growth phase, divided into 30 ml aliquots containing
16108 cells in fresh media and fixed with a final concentration of
0.8% formaldehyde at room temperature for 5 minutes. Reactions
were stopped by adding glycine to a final concentration of
0.125 M. The cells were washed in PBS and resuspended in cell
lysis buffer (0.25% Triton X-100, 10 mM EDTA, 0.5 mM EGTA,
10 mM Tris pH 8.0) to isolate nuclei. Chromatin was prepared
following washing (0.2 M NaCl, 1 mM EDTA, 0.5 mM EGTA,
10 mM Tris pH 8.0) and lysis (NLB: 50 mM Tris-HCl pH 8.0,
10 mM EDTA, 0.5% SDS) of nuclei. Crosslinked chromatin was
fragmented by sonicaton (Misonix) for a total time of 10 minutes
in regular 10 second pulses at 4uC. Debris was removed by
centrifugation at 15000 g for 10 minutes and chromatin was
diluted in 10 volumes of X-ChIP buffer (1.1% TX-100, 1.2 mM
EDTA, 16.7 mM Tris pH 8.1, 167 mM NaCl). Agarose gel
electrophoresis was used to confirm that chromatin fragments
were ,500 bp in length on average.
Chromatin was pre-cleared with 100 ml of protein A agarose
(50% slurry in X-ChIP buffer, Millipore) and 50 mg of normal
rabbit IgG (Santa Cruz) for 3 hours at 4uC on a rotating wheel.
Aliquots of chromatin were taken to generate input DNA and
protein for western analysis. Individual ChIPs were performed
using chromatin from 16107 cells in a total volume of 1 ml by
diluting the pre-cleared chromatin with modified X-ChIP buffer (1
part NLB to 9 parts X-ChIP). Incubation with antibodies was
performed overnight at 4uC on a rotating wheel. Between 10 and
30 mg of specific antibodies or 10 mg of normal rabbit IgG (Santa
Cruz) were used per ChIP. Chromatin was precipitated with
protein A agarose (50 ml slurry in X-ChIP, Millipore) for 4 hours
at 4uC with rotation. Immunoprecipitated chromatin was
collected, washed, eluted and crosslinks reversed. DNA was then
extracted by phenol-chloroform and ethanol precipitated in the
presence of 10 mg glycogen.
Relative DNA enrichments were quantified by TaqMan real-
time qPCR using the comparative Ct method relative to input
DNA and normalized to the primer set 10.35 within the 16 kb
condensed chromatin region upstream of the chicken b-globin locus
as described previously [14]. The TaqMan primer sets 10.35
(‘‘16 kb’’), 21.54 (HS4 core, ‘‘end HS4’’), 39.806 (beta-adult
promoter), 50.861 (39HS) and PGI59 (59 HS4 elements on IL-2R
transgene, ‘‘trans HS4’’) were used in this study.
10.35_For: GGAACAAGTTGGCAAGGTCCTAT
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10.35_Rev: TCTTCTGCCCTGCCCGTAT
10.35_TM: FAM-TGCAGTTCCCTGTTCATGTGCTTT-
TCG-TAMRA
21.54_For: TCCTGGAAGGTCCTGGAAG
21.54_Rev: CGGGGGAGGGACGTAAT
21.54_TM: 6FAM-CCCAAAGCCCCCAGGGATGT-TA-
MRA
39.8_For: CTGTGGTCTCCTGCCTCACA
39.8_Rev: AGGCTGGGTGCCCCTC
39.8_TM: FAM-CAATGCAGAGTGCTGTGGTTTGGAA-
CTG-TAMRA
PGI_59_For CACAGGAAACAGCTATGACATGATT
PGI_59_Rev TCTGCCTTCTCCCTGATAACG
PGI_59_TM 6FAM-AATTCCTGCCCACACCCTCCTGC-
TAMRA
ChIP analysis of transcription factor binding in murine
E14Tg2A.4 ES cell lines was performed using formaldehyde
crosslinked chromatin prepared from 16109 cells treated with 1%
formaldehyde for 5 minutes. Chromatin was prepared as de-
scribed above, where fragments sizes ranged from 500–700 bp.
Semi-quantitative PCR was performed using the following primers
APRT1/2_For: AAAGGCGTGCGGGAGCCAGAAAT
APRT1/2_Rev: CCTTGGTAGGTGGGG
APRT3_For: CCCTGTTCCTGGGCTCC
APRT3_Rev: TGACTGGCCAGGAGG
ChIP analysis from human embryonic kidney 293-T cell line
SD5 that contains a stably integrated copy of the 275 bp HS4 core
chicken insulator was performed as described for cultured chicken
cells above. SD5 cells were crosslinked with 1.6% formaldehyde
for 5 minutes. The following primers were used in SYBR
quantitative PCR analysis:
HS4_21.726_F: CGGGATCGCTTTCCTCTGA
HS4_21.726_R: CCGTATCCCCCAGGTGTCT
P_DHFR_F: TCGCCTGCACAAATAGGGAC
P_DHFR_R: AGAACGCGCGGTCAAGTTT
Control
VEZF1_CDS_F: GACAGCAGCCGAACTTCGTT
VEZF1_CDS_R: TGGTGCCCGAGGAAGATG
APRT elements. The following elements were amplified from
Hamster liver genomic DNA:
Wild-type APRT CpG island. Sp1-like motifs in red. AvaII and
HpaII restriction sites in bold.
CTAGAGGATCCGGACAACACCCACACCGGCCCC-
TCCAGGTCCAGAAAGCTGGCCCTGCGAGAAGCGGG-
ACTGAAAAGGCGTGCGGGAGCCAGAAATCCAAAAG-
GGTGCCAAGGCATGCGTCCTTTTTCCACCCAGAAA-
TAACCCCAGGCTTTCAATTTGAGGTTATTTCAAT-
ATCCAGCAAATGCGTTACTTCCTGCCAAAAGCCAG-
CCTCCCCGCAACCCACTCTCCCAGAGGCCCCGCCC-
CGTCCCGCCCCCTCCCGGCCTCTCCTCGTGCTGGA-
TCGCTCCCTAAGGACGCCCCGCTCCAGAAGCCCCA-
CCTACCAAGGACGCCCCACCCTTGTTCCCGGACTG-
GTATGACCCCAGCCTGCTGACATCCCTCCGCCCTT-
TCTCGTGCACGCGGCTATGGCGGAATCTGAGTTGC-
AGCTGGTGGCGCAGCGATCCGCAGTTTCCCCGACT-
TCCCCATCCCCGGCGTGCTGTTTAGGTGAGATCAC-
GAGCCAGCAAGGCGTTGGAGCCCTGTTCCTGGGCT-
CCCGGCGAGGCGCATGGGCAGTCTCGGGGATCTTG-
TGGGGTCTCCGCCCCCCTTTCCCCGGCCACCAGCC-
TCTCCTTGTTCCCAGGGATATCTCGCCCCTCCTGA-
AGGACCCCGCCTCCTTCCGAGCTTCCATCCGCCTC-
CTGGCCAGTCACCTTAAGTCCACGCATGGCGGCAA-
GATCGACTACATCGCAGGTCTA
Mutant APRT CpG island. Mutated bases in blue were
introduced by site directed mutagenesis. Overall CpG content
increased from 46 to 48 following these mutations. AvaII and HpaII
restriction sites in bold.
CTAGAGGATCCGGACAACACCCACACCGGCCCC-
TCCAGGTCCAGAAAGCTGGCCCTGCGAGAAGCGG-
GACTGAAAAGGCGTGCGGGAGCCAGAAATCCAAA-
AGGGTGCCAAGGCATGCGTCCTTTTTCCACCCAG-
AAATAACCCCAGGCTTTCAATTTGAGGTTATTTC-
AATATCCAGCAAATGCGTTACTTCCTGCCAAAAG-
CCAGCCTCCCCGCAACCCACTCTCCCAGAGACCC-
CCCGCATCCCCGACGCTACCCCCCGCATCCCCGA-
TCTCCTCGTGCTGGATCGCTCCCTAAGGACGCCC-
CGCTCCAGAAGCCCCACCTACCAAGGACGCCCCA-
CCCTTGTTCCCGGACTGGTATGACCCCAGCCTGC-
TGACATCCCTCCGCCCTTTCTCGTGCACGCGGCT-
ATGGCGGAATCTGAGTTGCAGCTGGTGGCGCAGC-
GATCCGCAGTTTCCCCGACTTCCCCATCCCCGGC-
GTGCTGTTTAGGTGAGATCACGAGCCAGCAAGGC-
GTTGGAGCCCTGTTCCTGGGCTCCCGGCGAGGCG-
CATGGGCAGTCTCGGGGATCTTGTGGGGTCCGCT-
CCCCCCGCATCCCCGACACCAGCCTCTCCTTGTT-
CCCAGGGATATCTCGCCCCTCCTGAAGGACCCCG-
CCTCCTTCCGAGCTTCCATCCGCCTCCTGGCCAG-
TCACCTTAAGTCCACGCATGGCGGCAAGATCGAC-
TACATCGCAGGTCTA
Non-CpG island from APRT locus. HpaII site in bold.
TCTAGATTGCTAGGAGTAGCACCTAAGATGAAC-
TAGATGCTAAAAAATGCTGTATCTTTGGGGCACAC-
GAGGGCATGCCTGGGCAGGCTTAGAGCCTGGTAGT-
CTCAGGGGCTGCACCAAAGTGTAATTCTTGTGCTA-
AATAACTTTCACTTACCAGTGCCAAGCACGGGCTT-
CAGAAACACCCTAGGGTCGCTGAATGTCCACCAGG-
GGAGTCAGACATGTCCAGAGGGTGAGAACCCCAGA-
GAATTCGGTAGCCCTGACATGTGCTACAATTACTG-
ATGCCCACTTCCTACTGGTTCCTCCTGGCCATACC-
TCAGGAATTAGGGCATGCTTTCTGCCTGCTACAGT-
AGCTCATCCTCCCTGGAAGTGACCCCAGACATATA-
CCCTGAACTGTAACCGATAAAGTGCGCCTGGGCAG-
ATGTATTTGAGAGGTGGCAAAAGTAAACCATAGGT-
GTCCCCGAGCTAGATACAGAAGGCAGATAACATCC-
CCAAGGCTAAGCTGCTGCCCCAATAGCCATCAGCC-
TTCTAGTTATAGCTAGTAAGACCTAGTATTCCTGG-
TCAATACTATTCACTCAATCCTTACACCTCAGCCC-
TAACACGCCCCCTCTCTCATCCTAACAGGCCTAGA-
CTCCAGGGGATTCTTGTTTGGCCCCTCCCTAGCTC-
AGGAGCTGGGCCTGGGCTGTGTGCTCATCCGGAAG-
CGAGGGAAGCTGCCAGGCCCCACAGTGTCAGCCTC-
CTATGCTCTCGAGTATGGCAAGGTAAGCAGGCAGT-
GGGTAGCTGTCTAGGAGTAAATGTGGGGGCTCAGA-
GAGGTTAAGTCATCAGGCCAGGTTTATACCACCAG-
GAAACATGGAGAAGCTAGGGGTGGTGGTTCTAGA
CpG island methylation assays
,720 bp wild type and mutant APRT CpG islands and an
870 bp non-island region of the APRT gene were cloned into
pUC19. Each element was PCR amplified, half of which was
subject to in vitro CpG methylation by M.SssI methyltransferase
(New England Biolabs). In vitro methylation was validated by HpaII
and MspI digestion. 1 mg of each APRT element was transfected
into murine E14Tg2A.4 ES cells (BayGenomics) with 1 mg of the
XbaI fragment of pREP7 (Invitrogen). Hygromycin resistant clones
were grown in LIF without feeder co-culture. Genomic DNA was
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extracted after two weeks of culture. Probes for Southern blotting
were generated using Ready-to-go dCTP beads (GE Healthcare).
Oligonucleotide sequences
Oligonucleotides were generated on an ABI 394 DNA
synthesizer.
The top strand sequences for each of the duplexes used for gel
mobility shift analyses were:
FI wt 59 GGAGCTCACGGGGACAGCCCCCCCCCAAA-
GCCCCCAGGGA,
FIII wt 59 aggcgcgccCCGGTCCGGCGCTCCCCCCGCAT-
CCCCGAGCCGGggcgcgcct,
FV wt 59 CCTGCAGACACCTGGGGGGATACGGGGA-
AAAAGCTTTAGG,
Sp1 59 ATTCGATCGGGGCGGGGCGAGC,
glo wt 59 AATTGCAGAGCTGGGAATCGGGGGGGGG-
GGGGGGGCGGGTGGTGGTGTGG,
glo 7G 59 AATTGCAGAGCTGGGAATCGGGGGGGC-
GGGTGGTGGTGTGG,
glo 6G 59 AATTGCAGAGCTGGGAATCGGGGGGCG-
GGTGGTGGTGTGG.
Asc I restriction sites used for cloning FIII sites in an earlier
study are shown as lower case. All FI and FIII oligonucleotides
were identical to the wt sequences above except for mutations
indicated in Figure 1E.
DNA affinity columns were prepared using the following
oligonucleotides
FI-DA TOP 59 gatcTCACGGGGACAGCCCCCCCCCAA-
AGCCCCCA
FI-DA BOTTOM 59 gatcTGGGGGCTTTGGGGGGGGG-
CTGTCCCCGTGA
FIII-DA TOP 59 gatcGGTCCGGCGCTCCCCCCGCATC-
CCCGAGCCGGCA
FIII-DA BOTTOM 59 gatcTGCCGGCTCGGGGATGCG-
GGGGGAGCGCCGGACC
PCR primers used in bisulfite sequencing were
HS4 59 double forward 59 GGTATTAGAGTAGATTGTA-
TTGAGAGTGTA
HS4 59 double reverse 59 CATAACTATTTCCTATATAA-
ATCCCC
HS4 59 single forward 59 AGAGTAGATTGTATTGAGAG-
TGTATTATA
HS4 59 single reverse 59 ACATCCCTAAAAACTTTAAAA-
AAAA
IL-2R forward 59 GTTAAGGTTGGGGGTTTTTT
IL-2R reverse 59 AAAACTCTACCTAACAACCAAACA-
C
PCR primers used in RT-PCR gene expression analysis were
GgVEZF805anti 59CAGTGCACGTTTGGCATTTGAAG
GgVEZF716sense 59GAAAAGGCTTCTCGAGGCCTGA-
TC
GgGAPDH-247T 59-6FAM-TCCAGGAGCGTGACCCCA-
GCA-TAMRA
GgGAPDH-226F 59 ATGGGCACGCCATCACTATC
GgGAPDH-302R 59 AACATACTCAGCACCTGCATCTG
GgB-ACTIN_F 59 TGCTGCGCTCGTTGTTGA
GgB-ACTIN_R 59 CATCGTCCCCGGCGA
GgB-ACTIN_T 59-6FAM-TGGCTCCGGTATGTGCAAG-
GCC-TAMRA
The primers used for methylation specific PCR analysis of the
APRT non-island element were:
APRTNI_59 TCTAGATTGCTAGGAGTAGC
APRTNI_39 TCTAGAACCACCCCTAGC
Supporting Information
Figure S1 Core HS4 sequences. (A) The 244 bp SacI - HindIII
fragment originally defined as the ‘‘250 bp core’’ HS4 element
[11]. Underlined bases indicate the positions of five in vitro DNaseI
footprints [11]. Bases in bold type have been shown to be essential
for DNA-binding of CTCF [9], USF1/2 [14], or VEZF1 (this
study). This 244 bp fragment alone has not been tested in either
enhancer blocking or barrier assays. (B) The 275 bp HS4 fragment
used to define insulator properties of the ‘‘250 bp core’’ in
enhancer blocking [9] and barrier assays [12]. Flanking AscI
cloning sites present in all functional assays of the HS4 core are
shown in italics.
Found at: doi:10.1371/journal.pgen.1000804.s001 (0.87 MB TIF)
Figure S2 Identification of FI- and FIII-binding proteins. (A)
Peptide sequences obtained from tandem MS sequencing of
proteins isolated by FI- and FIII-DNA affinity. (B) Alignment of
the amino acid sequences of chicken VEZF1/BGP1, human
VEZF1/DB1, and mouse Vezf1 (accession numbers AY775302,
1082846, and 7710108). Peptides obtained from tandem MS
sequencing that match VEZF1 are indicated by lines above the
alignment. Six C2H2 zinc fingers motifs are boxed. (C) Schematic
representation of the domain structure of VEZF1. Only the zinc
finger motifs share homology with factors other than VEZF1
orthologs, the nearest relative being the MAZ transcription factor.
Found at: doi:10.1371/journal.pgen.1000804.s002 (4.96 MB TIF)
Figure S3 Supershift analysis of VEZF1, SP1, SP3, and ZF5
interactions with HS4 footprints and the bA-globin promoter. Gel
mobility supershift assays using 32P-labelled FI (A), FIII (B), FV
(C), and glo wt (D) oligonucleotide duplexes. Adult chicken
erythrocyte nuclear extract (ery) and recombinant chicken
VEZF1, SP1, or SP3 used in the reactions are indicated by
brackets above the lanes. Proteins were pre-incubated with
antibodies (indicated above each lane) prior to incubation with
DNA. Supershifts are evidenced by abrogation of specific
complexes (asterisks) and/or formation of low mobility ternary
complexes (SS). Antibodies alone do not give rise to complexes
with any of the duplexes used (not shown).
Found at: doi:10.1371/journal.pgen.1000804.s003 (3.49 MB TIF)
Figure S4 Analysis of SP1, SP3, and ZF5 interactions with HS4
footprints I and III. Gel mobility shift assays using 32P-labelled FI
and FIII oligonucleotide duplexes. Unlabelled competitor duplexes
(indicated above each lane) were added at 50 fold molar excess.
Recombinant chicken SP1, SP3, and ZF5 used in the reactions are
indicated by brackets above the lanes. The competition profile of
these proteins does not match that of red blood cell nuclear extract
(Figure 4) or recombinant VEZF1 (Figure 6A).
Found at: doi:10.1371/journal.pgen.1000804.s004 (0.71 MB TIF)
Figure S5 SP1, SP3, and ZF5 do not interact with HS4 in vivo.
(A) ChIP analysis of transcription factor interactions at the b-globin
locus in 6C2 erythroid progenitor cells. DNA enrichments at the
{lower case beta}A promoter or the HS4 and 39HS insulators
were normalized to a negative control located in the 16 kb
condensed chromatin region upstream of the b-globin locus. (B)
ChIP analysis of transcription factor interactions with a stably
integrated HS4 element in transgenic human 293 cells. Interac-
tions with the DHFR CpG island promoter are shown as a positive
control for SP1 and SP3 binding. DNA enrichments are
normalized to an AT-rich negative control locus.
Found at: doi:10.1371/journal.pgen.1000804.s005 (0.49 MB TIF)
Figure S6 VEZF1 binding to HS4 is resistant to individual
binding site mutations. (A) Schematic representation of the IL-2R
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transgene showing location of QPCR primer sets used to analyze
the interaction of VEZF1 with the transgenic HS4 and promoter
elements. (B–D) ChIP analysis of (B) VEZF1, (C) CTCF, or (D)
USF1 interactions at the endogenous HS4 insulator (eHS4) and
the transgenic HS4 (tHS4) and promoter (b-IL2Rpro) elements in
the same 6C2 cell lines used for DNA methylation (Figure 3) and
histone modification [14] analysis. DNA enrichments were
normalized to a negative control located in the 16 kb condensed
chromatin region upstream of the b-globin locus. Deletion of either
footprint II or footprint IV disrupts CTCF and USF1 binding as
expected. In contrast, deletion of individual VEZF1 sites footprint
I, III, or V have no significant effect on overall VEZF1 ChIP
efficiency.
Found at: doi:10.1371/journal.pgen.1000804.s006 (1.09 MB TIF)
Figure S7 VEZF1 binding to HS4 is not significantly affected
following VEZF1 RNAi. (A) Quantitative RT-PCR analysis
following 48 hours of doxycycline-induction of two chicken 6C2
cell lines harboring lentiviral vectors that express VEZF1-specific
miRNA. Expression levels are normalized to those of b-actin
(ACTB) and untreated cells. VEZF1 mRNA levels are reproduc-
ibly knocked down by 70%. (B) Western blot analysis of chicken
VEZF1 protein levels in one of the above lines with and without
14 days of doxycycline induction of VEZF1-specific miRNA. TBP
levels were monitored as a loading control. VEZF1 and TBP band
intensities visualized on a FUJI LAS3000 imager were quantified
using AIDA software (shown below). Following normalization to
TBP levels, VEZF1 protein levels were quantified to be knocked
down by ,97%. VEZF1-specific miRNA may cause translational
inhibition in addition to the mRNA degradation observed by RT-
PCR (C) ChIP analysis of VEZF1 interaction with the endogenous
HS4 element following 14 days of induced VEZF1 knockdown.
DNA enrichments were normalized to a negative control located
in the 16 kb condensed chromatin region upstream of the b-globin
locus.
Found at: doi:10.1371/journal.pgen.1000804.s007 (1.64 MB TIF)
Figure S8 Transcription factor interactions with APRT CpG
island elements. VEZF1 and SP1 interact with the wild type APRT
CpG island, but the FIII mutant APRT element is only bound by
VEZF1. Gel mobility supershift assays using 32P-labelled oligonu-
cleotide duplexes containing either the wild type APRT SP1 sites
1&2 (lanes 1–4) and site 3 (lanes 5–8) or the mutant sites 1&2 (lanes
9–12) and site 3 (lanes 13–16). The core sequences of the duplexes
are as shown in figure 8a. Nuclear extracts were pre-incubated
with antibodies (indicated above each lane) prior to incubation
with DNA. Supershifts are evidenced by the formation of low
mobility ternary complexes (SS) in addition to abrogation of
specific complexes (asterisk). Antibodies alone do not give rise to
complexes with any of the duplexes used (not shown). SP1 and SP3
are detected in complexes with the wild type sites 1&2 and site 3
only. VEZF1 is detected in complexes with all four sites; weakest
binding is seen at wild type sites 1&2 and strongest binding is seen
at mutant sites 1&2.
Found at: doi:10.1371/journal.pgen.1000804.s008 (1.78 MB TIF)
Table S1 VEZF1 sites in the HS4 barrier protect a promoter
from DNA methylation. CpG methylation of transgene promoters
flanked by wild type or mutant HS4 insulators after 30 or 90 days
of culture. The scoring of individual CpG bases from each clone
subject to bisulfite sequencing is shown. Methylated bases are
marked as ‘1’ and shaded blue. Average CpG methylation values
are shown in Figure 5. Numbers above each table refer to CpG
numbering from [16], where CpG 4–11 and 12–18 reside in the
promoter and coding sequence, respectively.
Found at: doi:10.1371/journal.pgen.1000804.s009 (0.02 MB PDF)
Table S2 Mutations of insulator protein binding sites result in
the de novo methylation of HS4. CpG methylation of wild type
(WT) or mutant (DI - DV) HS4 insulators after 30 or 90 days of
culture. Both copies of HS4 were sequenced, except for DII and
DV, where only the outermost copy was sequenced (see Materials
and Methods). The scoring of individual CpG bases from each
clone subject to bisulfite sequencing is shown. Methylated bases
are marked as ‘1’ and shaded blue. Average CpG methylation
values are shown in Figure 3. Numbers above each table refer to
CpG numbering as assigned in Figure 3b.
Found at: doi:10.1371/journal.pgen.1000804.s010 (0.03 MB PDF)
Text S1 DNA binding activities of candidate HS4-binding
proteins; RNA interference methods; western blotting methods.
Found at: doi:10.1371/journal.pgen.1000804.s011 (0.04 MB
DOC)
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